7201 - 7210 of 8586 Results
Title
Year
-
RESTRICTEDTitle: Conquering Neurologic Diseases in Primary CareJournal Name: Primary Care: Clinics in Office PracticePublisher: Elsevier BVVol: 51Issue #: 2Start Page: xvEnd Page: xviPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001Citation Count: 0
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Best OA location URL: https://rupress.org/jcb/article-pdf/doi/10.1083/jcb.202311189/1932896/jcb_202311189.pdfCitation Count: 4
-
OPENTitle: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesisJournal Name: Protein SciencePublisher: WileyVol: 32Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pro.4728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10367600Citation Count: 2
-
OPENTitle: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00919-yBest OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148945Citation Count: 0
-
OPENTitle: Development of a simplified smell test to identify Parkinson’s disease using multiple cohorts, machine learning and item response theoryJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00904-5Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/148944Citation Count: 1
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte ChemiePublisher: WileyVol: 130Issue #: 18Start Page: 4980End Page: 4984Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ange.201710779Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fange.201710779Citation Count: 0
-
OPENTitle: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studiesJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 85Issue #:Start Page: 59End Page: 67.e6Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019Best OA location URL: https://doi.org/10.1016/j.annepidem.2023.04.019Citation Count: 3
-
OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6
-
OPENTitle: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSFJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0130-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0130-3Citation Count: 21
-
RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 32